/ /

  • linkedin
  • Increase Font
  • Sharebar

    Opternative and 1- 800 Contacts: Two wrongs don’t make a right


    The founder of Opternative is on record saying he “remains hopeful that optometrists will someday be willing to partner with Opternative and bring the technology into their own practices.”3 Look, ODs aren’t afraid of disruptive technology. We realize that change is coming and we as a profession have to be willing to adapt to survive. Yet Opternative’s desire to partner with optometry has been dealt a severe blow by the company’s decision to partner with and be exploited by a company who by its repeated actions put profits above the eye health of the patients we serve.

    The moral of an Aesop’s fable is a man is known by the company he keeps. With this agreement, Opternative will be forever linked with 1-800-Contacts and may have torpedoed any intent of working with optometry.


    1. Graham M. Opternative joins forces with 1-800-Contacts. Chicago Trib. Available at: http://www.chicagotribune.com/bluesky/originals/ct-opternative-1800-contacts-partnership-bsi-20160729-story.html. Accessed 8/4/16.

    2. McCarthy C. 1 800 Contacts now offers Opternative refraction to its customers. Opt Times. Available at: http://optometrytimes.modernmedicine.com/optometrytimes/news/1-800-conta.... Accessed 8/4/2016.

    3. American Optometric Association. Opternative’s doc locator appears to falsely imply endorsement. Available at: http://www.aoa.org/news/advocacy/aoa-opternatives-doc-locator-appears-to.... Accessed 8/4/2016.

    Ernie Bowling, OD, MS, FAAO
    Dr. Ernie Bowling is Chief Optometric Editor of Optometry Times. He received his Doctor of Optometry and Master of Science in ...


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Optometry Times A/V